Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Myasthenia Gravis × Cognitive Behavioral Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sleep Initiation and Maintenance Disorders 28 Neoplasms 20 Breast Neoplasms 18 Depression 10 Anxiety Disorders 10 Prostatic Neoplasms 8 Fatigue 8 Lung Neoplasms 5 Motor Activity 4 Lymphoma 4 Weight Loss 3 Melanoma 3 Chronic Pain 3 Smoking Cessation 2 Sleep Wake Disorders 2 Pain 2 Overweight 2 Obesity 2 Nervous System Diseases 2 Multiple Myeloma 2 Glioma 2 Glioblastoma 2 Cognitive Dysfunction 2 Carcinoma, Non-Small-Cell Lung 2 Weight Gain 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Tobacco Use Disorder 1 Substance-Related Disorders 1 Stress, Psychological 1

Interventions

rozanolixizumab 9 zilucoplan 7 efgartigimod alfa 7 telitacicept 6 Rituximab 6 Cyclophosphamide 6 fludarabine 5 eculizumab 5 Prednisone 5 Pyridostigmine Bromide 4 Hizentra 4 ravulizumab 3 Tacrolimus 3 HBM9161 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Prednisolone 2 Mycophenolic Acid 2 Immunoglobulins, Intravenous 2 tofacitinib 1 tocilizumab 1 satralizumab 1 sargramostim 1 rhoA GTP-Binding Protein 1 remibrutinib 1 prednylidene 1 iptacopan 1 gamma-Globulins 1 deltacortene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06659627 2025-09-09

FIT to ACT-MG

Leiden University Medical Center

Phase NA Recruiting

Fatigue, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡